News

Bayer appoints new head of IP ...
ANN ARBOR, Mich., July 01, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it has appointed Craig Thompson, Chief Executive Officer of Cerevance, to its Board of Directors. Mr.
The U.S. Supreme Court on Monday requested the opinion of the Solicitor General in a legal dispute involving Bayer’s ( ...
Following Bayer's acquisition of Schering in 2006, Sebastian served as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey.
His experience extends way beyond there, though; Guth has been with Bayer’s pharma business before it was Bayer’s pharma business. He joined Schering AG as a project lead in Asia and the ...
As a member of the Board of Management and Labor Director of Bayer Schering Pharma AG, Berlin, Germany, from 2006 through September 2009, his roles included actively participating in this company ...
Received income in an amount equal to or greater than $250 from: Bayer Schering Pharma AG; DebioPharma SA; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co., Ltd.; ...
Received income in an amount equal to or greater than $250 from: Bayer Schering Pharma AG; DebioPharma SA; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co., Ltd.; ...
In Gedeon Richter plc v Bayer Schering Pharma AG [2011] EWHC 583 (Pat), Gedeon Richter plc applied to have two divisional patents belonging to Bayer Schering Pharma AG revoked for invalidity (the ...
Berlin, May 7, 2010 - Bayer Schering Pharma AG, Germany, today announced that the company has started to enroll patients in an international Phase III trial to evaluate its investigational ...